Journal article
Financial disclosure and clinical research: What is important to participants?
A Hutchinson, AR Rubinfeld
Medical Journal of Australia | AUSTRALASIAN MED PUBL CO LTD | Published : 2008
Abstract
Objective: To assess what participants in company-sponsored clinical trials wish to know about financial aspects of the study. Design, setting and participants: Cross-sectional questionnaire administered to 324 participants in six clinical trials conducted at the Royal Melbourne Hospital in 1999-2000 and 2006 for non-acute conditions (asthma, chronic obstructive pulmonary disease, osteoporosis, rheumatoid arthritis, diabetes and influenza vaccine efficacy). Main outcome measures: Participants' desire for information on study funding, investigators' conflicts of interest, and use of accrued funds. Results: 259 participants (80%) completed the survey. Participants wanted to be informed about t..
View full abstractGrants
Funding Acknowledgements
Abe Rubinfeld has received honoraria for professional lectures from GlaxoSmithKline (GSK), Astra-Zeneca, Pfizer and Boehringer Ingelheim, and has participated in clinical trials conducted on behalf of GSK, AstraZeneca, Roche, ALTANA Pharma, Merck Sharp & Dohme and Bristol-Myers Squibb. No outside interests were involved in the conduct of this project or writing of this paper. This study was funded by the Respiratory Medicine Special Purposes Fund, Royal Melbourne Hospital, which has been accrued from participation in various company-sponsored clinical trials.